SCHEMBL255895

SCHEMBL255895

CC(C)(C)OC(=O)N1CC(N2CC(N)C2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
HPGD P15428 1/20 0.40
RECQL P46063 1/20 0.38
EPHX1 P07099 1/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38
THRB P10828 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
NAMPT P43490 1/20 0.37
USP30 Q70CQ3 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121357 0.87 NR1H2 (0.54) NR1H2USP2SMN1; SMN2CHRM2CHRM1
Hydrochloric Acid SCHEMBL20516045 0.85 NR1H2 (0.53) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL1675672 0.85 HPGD (0.50) USP2SMN1; SMN2HPGDRECQLEPHX1
SCHEMBL2673809 0.84 NR1H2 (0.49) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL20635218 0.83 NR1H2 (0.45) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL2673498 0.83 NR1H2 (0.47) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL20635222 0.81 NR1H2 (0.43) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL24359058 0.81 NR1H2 (0.49) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL15664395 0.81 HPGD (0.51) NR1H2USP2SMN1; SMN2CHRM2CHRM1
SCHEMBL24447236 0.80 NR1H2 (0.56) NR1H2USP2SMN1; SMN2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012030907-A1 DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-03-08 WO disclosed